These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2572460)

  • 1. Inflammatory bowel disease and male infertility: effects of sulfasalazine and 5-aminosalicylic acid on sperm-fertilizing capacity and reactive oxygen species generation.
    Wu FC; Aitken RJ; Ferguson A
    Fertil Steril; 1989 Nov; 52(5):842-5. PubMed ID: 2572460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfasalazine-induced abnormal sperm penetration assay reversed on changing to 5-aminosalicylic acid enemas.
    Chatzinoff M; Guarino JM; Corson SL; Batzer FR; Friedman LS
    Dig Dis Sci; 1988 Jan; 33(1):108-10. PubMed ID: 2892654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfasalazine-induced abnormal sperm penetration.
    Riley SA
    Dig Dis Sci; 1988 Nov; 33(11):1498-9. PubMed ID: 2903015
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversal of male infertility on changing treatment from sulphasalazine to 5-aminosalicylic acid.
    Cann PA; Holdsworth CD
    Lancet; 1984 May; 1(8386):1119. PubMed ID: 6144844
    [No Abstract]   [Full Text] [Related]  

  • 5. [5-ASA versus sulfasalazine].
    Varela E
    Acta Gastroenterol Latinoam; 1994; 25(5):317-9. PubMed ID: 7785405
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnosis of drug-related male infertility by zona-free hamster egg sperm penetration assay.
    Margalioth EJ; Navot D; Beyth Y
    Lancet; 1985 Aug; 2(8449):275. PubMed ID: 2862444
    [No Abstract]   [Full Text] [Related]  

  • 7. Reversal with balsalazide of infertility caused by sulphsalazine.
    McIntyre PB; Lennard-Jones JE
    Br Med J (Clin Res Ed); 1984 Jun; 288(6431):1652-3. PubMed ID: 6144351
    [No Abstract]   [Full Text] [Related]  

  • 8. Sulphasalazine-induced reversible male infertility.
    Delaere KP; Strijbos WE; Meuleman EJ
    Acta Urol Belg; 1989; 57(1):29-33. PubMed ID: 2566274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Salicylic derivatives in the clinical treatment of inflammatory bowel disease: new perspectives].
    Damião AO; Sipahi AM
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(5):271-8. PubMed ID: 2576896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminosalicylates: old and new.
    Hanauer SB
    Mt Sinai J Med; 1990 Oct; 57(5):283-7. PubMed ID: 1982892
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of salazosulphapyridine and 5-aminosalicylic acid on seminal qualities and male sex hormones.
    Zelissen PM; van Hattum J; Poen H; Scholten P; Gerritse R; te Velde ER
    Scand J Gastroenterol; 1988 Nov; 23(9):1100-4. PubMed ID: 2907823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulphasalazine-induced infertility reversed on transfer to 5-aminosalicylic acid.
    Shaffer JL; Kershaw A; Berrisford MH
    Lancet; 1984 Jun; 1(8388):1240. PubMed ID: 6144952
    [No Abstract]   [Full Text] [Related]  

  • 13. [New salicylic acid derivatives in the treatment of inflammatory intestinal diseases].
    Kovács A
    Orv Hetil; 1991 Jun; 132(24):1317-21. PubMed ID: 1677465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experiences with phase III studies in the area of gastroenterology].
    Kruis W
    Verh Dtsch Ges Inn Med; 1991; 97():503-6. PubMed ID: 1687301
    [No Abstract]   [Full Text] [Related]  

  • 15. A possible mechanism of action of sulfasalazine and 5-aminosalicylic acid in inflammatory bowel diseases: interaction with oxygen free radicals.
    Del Soldato P; Campieri M; Brignola C; Bazzocchi G; Gionchetti P; Lanfranchi GA; Tamba M
    Gastroenterology; 1985 Nov; 89(5):1215-6. PubMed ID: 2864302
    [No Abstract]   [Full Text] [Related]  

  • 16. Sulphasalazine induced seminal abnormalities in ulcerative colitis: results of mesalazine substitution.
    Riley SA; Lecarpentier J; Mani V; Goodman MJ; Mandal BK; Turnberg LA
    Gut; 1987 Aug; 28(8):1008-12. PubMed ID: 2889648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of 5-aminosalicylic acid-containing drugs on sulfide production by sulfate-reducing and amino acid-fermenting bacteria.
    Edmond LM; Hopkins MJ; Magee EA; Cummings JH
    Inflamm Bowel Dis; 2003 Jan; 9(1):10-7. PubMed ID: 12656132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfasalazine and new analogues in inflammatory bowel disease, with focus on Crohn's disease.
    van Hees PA
    Acta Gastroenterol Belg; 1987; 50(5):555-9. PubMed ID: 2902723
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug treatment and formation of eicosanoids in patients with chronic inflammatory bowel disease.
    Lauritsen K
    Dan Med Bull; 1989 Sep; 36(4):378-93. PubMed ID: 2572403
    [No Abstract]   [Full Text] [Related]  

  • 20. Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases.
    Kandula M; Sunil Kumar KB; Palanichamy S; Rampal A
    Int Immunopharmacol; 2016 Nov; 40():443-451. PubMed ID: 27716592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.